Skip to main content
. 2019 Oct 23;2019:9146827. doi: 10.1155/2019/9146827

Table 2.

The laboratory and lung function tests and questionnaires of the Tai Chi Chuan (TCC) and control group at baseline.

TCC (n = 25) Control (n = 15) p value
Leukocytes (/μL) 9083.6 ± 491.7 (7480–10430) 8006.7 ± 385.3 (6960–9200) 0.204
Eosinophils (/μL) 552.8 ± 81.4 (295.4–663.5) 347.1 ± 72.4 (118.8–510.6) 0.067
Treg percentage of CD4 (%) 1.95 ± 0.16 (1.30–2.40) 2.07 ± 0.41 (1.41–2.39) 0.824
IgE (IU/mL) 577.4 ± 131.4 (133.3–755.0) 503.4 ± 111.2 (50.2–861.0) 0.966
FEV1 (L) 1.38 ± 0.06 (1.22–1.48) 1.39 ± 0.08 (1.20–1.67) 1.000
FEV1 predicted (%) 89.9 ± 3.1 (80.0–98.6) 92.3 ± 3.3 (83.0–101.5) 0.564
PEFR (L/min) 306.4 ± 13.8 (265.5–349.0) 321.1 ± 17.5 (280.5–352.5) 0.447
PEFR predicted (%) 78.2 ± 4.0 (64.5–82.6) 81.2 ± 3.0 (75.1–90.0) 0.329
FVC (L) 1.60 ± 0.08 (1.32–1.78) 1.63 ± 0.12 (1.26–2.12) 0.952
FVC predicted (%) 87.7 ± 3.0 (77.5–96.8) 92.0 ± 5.3 (77.0–101.0) 0.627
FeNO (ppb) 13.8 ± 2.1 (6–19.5) 14.3 ± 3.7 (4–26) 0.595
C-ACT 20.6 ± 0.9 (18–24) 23.5 ± 0.4 (23–24) 0.045
PAQLQ(S) 139.3 ± 3.9 (130.5–156) 150.0 ± 2.2 (141–158) 0.065

Data shown are mean ± SE (interquartile range). Treg, regulatory T cells; IgE, immunoglobulin E; FEV1, forced expiratory volume in one second; predicted (%), the percentage of predicted value according to the age, sex, body weight, and height with reference from the Ministry of Health and Welfare in Taiwan; PEFR, peak expiratory flow rate; FVC, forced vital capacity; FeNO, fractional exhaled nitric oxide; C-ACT, childhood asthma control test; PAQLQ(S), the standardized pediatric asthma quality of life questionnaire. Reference range: leukocytes, 4000–10500/μL; eosinophils, 50–250/μL; IgE, <100 IU/mL; FeNO, a higher level correlates with airway inflammation: <20 ppb as low, 20–30 ppb as moderate, and >35 ppb as high concentration; C-ACT, a higher score reflects better controlled asthma: ≥20 as well controlled and ≤19 as not well controlled; PAQLQ(S), a higher score reflects better quality of life.